About chemotherapy?
Hello Dr.
Yang, my father was hospitalized on April 26 at Tri-Service General Hospital in Neihu due to a suspected stroke (he was conscious at the time).
After emergency treatment, he was diagnosed with lung cancer, which has progressed to stage IV.
The doctors diagnosed that the cancer cells have metastasized to the brain, pressing on the nerves (I am paraphrasing; it is correct that the cancer cells have spread to the brain, but I am unsure about the specifics of how it affects the brain).
He has been experiencing dizziness for two weeks and is unable to move or exert strength in his right hand and right leg.
He has received IV fluids and several sessions of radiation therapy, and currently shows no external symptoms or pain, remaining conscious.
He is now hospitalized awaiting chemotherapy.
I have the following three questions:
1.
Can a stage IV lung cancer patient tolerate chemotherapy? If chemotherapy is not chosen and there are no obvious symptoms yet, generally speaking, how much longer can one expect to live? If chemotherapy is administered and the condition improves, is there a possibility of reducing cancer cells or preventing further spread? How much longer might one expect to live in that case?
2.
For stage IV cancer patients, which is considered terminal, how many days of chemotherapy are typically required each month? If the patient's family lives far from the hospital, can a terminal patient request hospitalization?
3.
Is it possible that there could be discrepancies in the test results? I would like to gather various professional opinions, and I kindly ask for your response, Dr.
Yang.
Thank you!
Fanny, 20~29 year old female. Ask Date: 2002/05/08
Dr. Yang Youhua reply Oncology
Patients with brain metastases have an average life expectancy of only one to two months if left untreated.
However, with the addition of radiation therapy, the average survival can be extended by four to five months.
Most patients pass away within a year, and surviving beyond a year is considered a very good outcome.
For terminal patients who cannot manage symptoms at home, it is advisable to seek assistance from healthcare facilities that offer palliative care services.
Reply Date: 2002/05/08
More Info
Understanding chemotherapy options for patients with Stage IV lung cancer is crucial, especially when the disease has metastasized to critical areas such as the brain. In your father's case, it is essential to consider several factors regarding his treatment options, prognosis, and the overall management of his condition.
1. Can Stage IV lung cancer patients tolerate chemotherapy?
Yes, many patients with Stage IV lung cancer can undergo chemotherapy, but the decision depends on various factors, including the patient's overall health, performance status, and the extent of metastasis. Chemotherapy can help manage symptoms, reduce tumor size, and potentially prolong survival. However, it is important to note that the side effects can be significant, especially in patients with advanced disease. If your father is otherwise healthy and has a good performance status, he may be a candidate for chemotherapy.
If chemotherapy is not chosen, the prognosis can vary widely. Generally, Stage IV lung cancer has a poor prognosis, with median survival times ranging from several months to a year, depending on various factors such as the patient's overall health, response to treatment, and specific characteristics of the cancer. If your father does not exhibit significant symptoms, he may have a limited time without treatment, but this is highly individualized.
2. How often is chemotherapy administered, and can patients request hospitalization?
Chemotherapy regimens for lung cancer typically involve cycles of treatment followed by rest periods. A common regimen might involve treatment every three weeks, but this can vary based on the specific drugs used and the patient's response. For patients with advanced cancer, especially those who may have difficulty traveling to the hospital, hospitalization for chemotherapy can be arranged. This is particularly important if the patient experiences significant side effects or requires supportive care during treatment.
3. Is there a possibility of error in diagnostic testing?
While diagnostic tests such as imaging studies and biopsies are generally reliable, there can be variations in interpretation or changes in the disease state over time. It is always advisable to discuss any concerns about test results with the treating physician. If there is uncertainty, a second opinion or further testing may be warranted to ensure an accurate understanding of the disease's progression.
In summary, your father's treatment plan should be tailored to his specific situation, taking into account his overall health, the extent of the disease, and his preferences. Chemotherapy can be a viable option, but it is essential to weigh the potential benefits against the risks and side effects. Regular communication with the healthcare team will be vital in navigating this challenging journey.
Similar Q&A
Surgical Treatment Options for Stage IV Lung Adenocarcinoma: Risks and Benefits
Director Huang, I would like to seek your expertise regarding my mother, who is 68 years old. In January 2017, a CT scan revealed a 2 cm tumor in the lower right lung. Follow-up biopsies and Tc-99m MDP scans confirmed stage IV lung adenocarcinoma with metastasis to the ribs and v...
Dr. Huang Yiwen reply Pulmonology
DEAR AKIRA: Stage IV lung cancer is generally inoperable; however, if there is downstaging after targeted therapy, surgery is certainly recommended as it tends to have a higher survival rate. If surgery is not an option, there are many medications available for lung adenocarcinom...[Read More] Surgical Treatment Options for Stage IV Lung Adenocarcinoma: Risks and Benefits
Understanding Stage IV Lung Cancer: Survival Rates and Treatment Options
Hello Dr. Ke, my father is 60 years old and is currently receiving chemotherapy for advanced lung cancer at Tri-Service General Hospital. His condition initially involved metastasis to the brain, resulting in right-sided hemiplegia. After one or two sessions of radiation therapy,...
Dr. Ke Zhengchang reply Pulmonology
Hello: In stage IV lung cancer with brain metastasis, the average survival is typically only three to six months. Therefore, even with chemotherapy, the average additional survival time is only extended by two to four weeks. Family members should be psychologically prepared. Ke Z...[Read More] Understanding Stage IV Lung Cancer: Survival Rates and Treatment Options
Understanding Stage 4 Lymphoma: Options and Hope for Patients
Hello, I would like to ask if there is really no hope for stage IV lymphoma that has metastasized to the lungs (with half of the lungs affected). It has been a year since the onset of the disease... All treatments for lymphoma have been administered, and radiation therapy has bee...
Dr. Lai Yicheng reply Oncology
Dear Sir/Madam, Thank you for your letter. I would like to clarify that the description of the treatment regimen for lymphoma is unclear, such as which specific medications were administered. It is difficult to provide you with comprehensive advice. However, I can offer general ...[Read More] Understanding Stage 4 Lymphoma: Options and Hope for Patients
Exploring Treatment Options for Stage III Lung Adenocarcinoma
A 30-year-old male with stage III lung adenocarcinoma who is inoperable and has not responded to targeted therapy. Aside from chemotherapy, are there any other treatment options available, and what is the potential prognosis?
Dr. Ke Zhengchang reply Pulmonology
Hello: Based on your description, if oral targeted therapy is ineffective, it is recommended to proceed with chemotherapy (first-line chemotherapy, such as Gemcitabine + Cisplatin). If that is also ineffective, second-line chemotherapy options (such as Paclitaxel or Irinotecan) c...[Read More] Exploring Treatment Options for Stage III Lung Adenocarcinoma
Related FAQ
(Oncology)
Terminal Stage(Oncology)
Cancer Treatment(Oncology)
Nasopharyngeal Cancer(Oncology)
Leukemia(Oncology)
Bile Duct Cancer(Oncology)
Pancreatic Cancer(Oncology)
Palliative Care(Oncology)
Other(Oncology)
Anemia(Oncology)